Behind the headlines

30 November 2018
Autumn 2018

Dr David Robert Grimes looks at the eye health issues that are making the news.

/COO/media/Media/Acuity/Autumn 2018/Behind-headlines-avastin-CREDIT-Alamy-600x400_1.jpg

NHS to save millions on AMD treatment

A landmark ruling promises to substantially reduce the cost of treating wet age-related macular degeneration (AMD) – and has significant implications for future drug policy. Bayer and Novartis had attempted to stop clinical commissioning groups (CCGs) from prescribing Avastin – a widely used and cheaper treatment, but unlicensed for AMD.

In September, the High Court ruled against the drug giants. 

Sign in to continue

Forgotten password?

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

This year's National Eye Health Week will take place from 18 to 24 September 2023, promoting the importance of good eye health and the need for regular sight tests for all.

Abstracts from the online Women in Vision UK Annual Meeting 2022 are presented.

For the very last issue of Optometry in Practice, Professor Jonathan Jackson MCOptom reflects on the past two decades of the journal and its contribution to our learning.